Media passes are available for the International BioFest 2016. The conference, hosted by AusBiotech, Australia’s biotechnology organisation, will draw researchers, industry leaders and investors to Melbourne for the largest-ever gathering in the Australian life sciences.
With a refreshing focus on innovation in Australian public policy, both industry and researchers are building an exciting environment for the Australian life sciences, of which there has been no better time to take part.
The International BioFest will celebrate Australian and international life sciences and highlight Melbourne as one of the world’s greatest biotechnology hubs from 24 – 27 October 2016 at the Melbourne Convention Centre. It will feature three major conferences coming together in one week in one place as one integrated network, including:
• 17th International Biotechnology Symposium (IBS 2016), presenting the most advanced issues in biotechnology green chemistry and its related fields;
• AusBiotech 2016, providing a vital forum to gather, learn and connect and the flagship event to advance Australia’s life sciences sector; and
• Australia Biotech Invest 2016, Australia’s life science investment showcase.
The International BioFest will feature more than 270 biotechnology experts from around the world and include 100 exhibitors representing industry, research and investment in the life sciences. Almost 40 per cent of delegates are expected to attend from overseas, travelling from almost 40 countries.
The conference will also draw a large delegation of pharmaceutical companies, including Bristol-Myers Squibb, who are seeking investment opportunities in Australia’s world-class pipeline of biotechnology. AusPartnering, AusBiotech’s business matching program, will facilitate meetings between delegates and a host of satellite events will offer valuable networking opportunities.
Glenn Cross, CEO of AusBiotech, said, “The International BioFest offers a holistic view of the global biotechnology ecosystem with events dedicated to academia, industry and investment. Drawing researchers, industry leaders, investors and companies to Melbourne, it facilitates valuable discussion in life sciences innovation and offers outstanding networking opportunities to delegates.”
Prof Sally McArthur, IBS 2016 speaker and Director, Swinburne Innovation Precinct said: “We get both the industry pull and the academic knowledge coming together at the International BioFest.”
- MORE -
Speakers include:
• Paul Perreault, CEO and Managing Director, CSL Ltd, USA
• Distinguished Prof Margaret Brimble, Chair of Organic Chemistry and Director of Medicinal Chemistry at the University of Auckland, describing how the discovery and development of peptide therapeutics become cancer vaccines and agents to treat neurogenetic disorders, infectious disease and diabetes;
• Radek Sali, Chief Executive Officer, Swisse Wellness Pty Ltd, presenting The Science of Swisse;
• Prof Sir Peter Gluckman, Chief Science Advisor to the Prime Minister, Office of the Prime Minister, New Zealand, discussing Biotechnology and innovation: risk and precaution: social license or not?
• Prof Dennis Liotta, Executive Director Emory Institute for Drug Development, Emory College, Atlanta USA, exploring A New Model for Drug Development in Academic Institutions;
• Prof Ian Gust AO, will delivering the Millis Oration and reflecting on the biotechnology industry past; • Prof Laura Cipolla, Milano-Bicocca University, Italy, presenting nanostructured biomaterials for tissue regeneration; and
• Dr Kade Roberts, Senior Research Scientist, Monash University will talk about ‘improving ‘last resort’ antibiotics’.
Registration is now open. Visit the website to view the full program, registration details and further information: www.internationalbiofest.org.
About AusBiotech
AusBiotech is Australia’s biotechnology organisation, working on behalf of members for 30 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural, environmental and industrial sectors.
